Treating Brain Metastases
Neurologist David Schiff discusses the significance of new evidence-based guidance on how to treat brain metastases from solid tumors.
Progress Against Cancer
Neurologist David Schiff discusses the significance of new evidence-based guidance on how to treat brain metastases from solid tumors.
Cardiovascular mortality rates for survivors of early-stage Hodgkin lymphoma outpace cancer-related mortality.
Technology could help detect lymphedema earlier.
Scientists look to decode the role of intestinal bacteria in our responses to immunotherapy.
Cancer treatment is a double-edged sword. Intense or multi-pronged treatment may lead to better killing of tumor cells, but it can often cause debilitating side effects. Is it possible to reduce the intensity of...
The new AKT inhibitor doubled progression-free survival when added to treatment with Faslodex.
Study finds pausing endocrine therapy is safe for early-stage breast cancer patients eager to expand their families.
Black breast cancer patients had worse outcomes in a recent study, even when cancer features aligned with white patients.
AACR patient advocate forum addresses developments in cancer early detection tests.
Five years after the FDA approved the first CAR T-cell therapy, use of the treatment has expanded to many patients with blood cancer.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now